Summary of Modified Risk Tobacco Product Application Submitted to U.S. FDA on December 5, 2016 Introduction
نویسنده
چکیده
Under Section 911 of the Family Smoking Prevention and Tobacco Control Act (Tobacco Control Act), signed into law in 2009, manufacturers can submit applications for FDA authorization to market tobacco products with claims of either reduced risk or reduced exposure (Modified Risk Tobacco Products; MRTPs). Such applications must be supported by adequate scientific evidence as detailed in the Tobacco Control Act.
منابع مشابه
Comments on the article entitled “ Heat - Not - Burn Tobacco Cigarettes : Smoke by Any Other Name ” by Auer R
Philip Morris International (PMI) supports scientific data transparency, data sharing and actively encourages the conduct of independent studies on IQOS that are aimed at advancing scientific and medical knowledge or verifying the results we obtained through our assessment program described by Smith MR, 2016. To date we have published over 30 peer-reviewed articles describing studies specifical...
متن کاملHeat-Not-Burn Tobacco Cigarettes: Smoke by Any Other Name.
Philip Morris International (PMI) supports scientific data transparency, data sharing and actively encourages the conduct of independent studies on IQOS that are aimed at advancing scientific and medical knowledge or verifying the results we obtained through our assessment program described by Smith et al. To date we have published over 30 peer-reviewed articles describing studies specifically ...
متن کاملUnderstanding how perceptions of tobacco constituents and the FDA relate to effective and credible tobacco risk messaging: A national phone survey of U.S. adults, 2014–2015
BACKGROUND The passage of the 2009 Family Smoking Prevention and Tobacco Control Act has necessitated the execution of timely, innovative, and policy-relevant tobacco control research to inform Food and Drug Administration (FDA) regulatory and messaging efforts. With recent dramatic changes to tobacco product availability and patterns of use, nationally representative data on tobacco-related pe...
متن کاملTobacco Product Use Among Adults - United States, 2013-2014.
While significant declines in cigarette smoking have occurred among U.S. adults during the past 5 decades, the use of emerging tobacco products* has increased in recent years (1-3). To estimate tobacco use among U.S. adults aged ≥18 years, CDC and the Food and Drug Administration (FDA) analyzed data from the 2013-2014 National Adult Tobacco Survey (NATS). During 2013-2014, 21.3% of U.S. adults ...
متن کاملPolicy and health implications of using the U.S. Food and Drug Administration product design approach in reducing tobacco product risk.
Purported risk or harm reduction through product design change of cigarettes has occurred in three phases in the U.S. The first phase from the 1940s to the early 1960s included a gradual rise in filtered cigarettes. The second phase, which began in the early 1960s in response to the landmark 1964 U.S. Surgeon General's report that linked smoking with lung cancer and other diseases, included the...
متن کامل